Cargando…

Is There a Role for Hypolipidaemic Drug Therapy in the Prevention or Treatment of Microvascular Complications of Diabetes?

Detalles Bibliográficos
Autores principales:	Mitsiou, Eydoxia K, Athyros, Vasilios G, Karagiannis, Asterios, Mikhailidis, Dimitri I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Open 2012
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319909/ https://www.ncbi.nlm.nih.gov/pubmed/22481984 http://dx.doi.org/10.2174/1874192401206010028

Ejemplares similares

Dyslipidemia Induced by Drugs Used for the Prevention and Treatment of Vascular Diseases
por: Tziomalos, Konstantinos, et al.
Publicado: (2011)

The clinical benefit of implementing guidelines in cardiovascular disease prevention in real world settings
por: Athyros, Vasilios G., et al.
Publicado: (2012)

Dyslipidaemia of Obesity, Metabolic Syndrome and Type 2 Diabetes Mellitus: the Case for Residual Risk Reduction After Statin Treatment
por: Athyros, Vasilios G, et al.
Publicado: (2011)

Preventing Cardio-renal Syndrome Rather than Treating It: Could Statins Play A Role?
por: Athyros, Vasilios G, et al.
Publicado: (2011)

Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment?
por: Athyros, Vasilios G., et al.
Publicado: (2011)

Single-pill combinations: a therapeutic option or necessity for vascular risk treatment?
por: Katsiki, Niki, et al.
Publicado: (2013)

Differential residual dyslipidemia/cardiovascular risk after statin treatment between Asian-Indians and western whites. Call for action
por: Athyros, Vasilios Gabriel, et al.
Publicado: (2016)

Are we getting to lipid targets in real life?
por: Katsiki, Niki, et al.
Publicado: (2010)

Patient with Hypertriglyceridemia, Type 2 Diabetes, and Chronic Kidney Disease Treated with Atorvastatin and Omega-3 Fatty Acid Ethyl Esters
por: Athyros, Vasilios G, et al.
Publicado: (2012)

Off target effects of statins shape total mortality?
por: Athyros, Vasilios G., et al.
Publicado: (2016)

Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients(§)
por: Athyros, Vasilios G, et al.
Publicado: (2007)

IMproving the imPlemEntation of cuRrent guidelines for the mAnagement of major coronary hearT disease rIsk factors by multifactorial interVEntion. The IMPERATIVE renal analysis
por: Athyros, Vasilios G., et al.
Publicado: (2011)

Statins and cardiovascular outcomes in elderly and younger patients with coronary artery disease: a post hoc analysis of the GREACE study
por: Athyros, Vasilios G., et al.
Publicado: (2013)

Evaluation of Hypolipidaemic Activity of Capparis decidua
por: Chahlia, Neelkamal
Publicado: (2009)

Diabetic Microvascular Complications
por: Migdalis, I., et al.
Publicado: (2018)

Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study
por: Athyros, Vassilios G., et al.
Publicado: (2011)

Hypolipidaemic and Insulin Secretagogue Activities of (R)-(−)-Carvone
por: Abbas, Manal Ahmad, et al.
Publicado: (2020)

Prospects of stem cell therapy for diabetic microvascular complications
por: Naruse, Keiko
Publicado: (2022)

Is There an Association Between Carotid-Femoral Pulse Wave Velocity and Coronary Heart Disease in Patients with Coronary Artery Disease: A Pilot Study
por: Katsiki, Niki, et al.
Publicado: (2016)

Comparative Effect of Atorvastatin and Rosuvastatin on 25-hydroxy-Vitamin D Levels in Non-diabetic Patients with Dyslipidaemia: A Prospective Randomized Open-label Pilot Study
por: Anagnostis, Panagiotis, et al.
Publicado: (2014)

The Mechanisms Underlying the Hypolipidaemic Effects of Grifola frondosa in the Liver of Rats
por: Ding, Yinrun, et al.
Publicado: (2016)

Role of Hyperbaric Oxygen Therapy on Microvascular Diabetic Complications and Metabolic Profile among Patients with Type 2 Diabetes Mellitus
por: Al-Rawahi, Abdulhakeem
Publicado: (2020)

HEXANE EXTRACT OF Dacryodes edulis FRUITS POSSESSES ANTI-DIABETIC AND HYPOLIPIDAEMIC POTENTIALS IN ALLOXAN DIABETES OF RATS
por: Okolo, Chidinma A., et al.
Publicado: (2016)

Implementation of Guidelines for the Management of Arterial Hypertension. The Impulsion Study
por: Karagiannis, Asterios, et al.
Publicado: (2009)

Hypoglycaemic and Hypolipidaemic Effects of Withania somnifera Root and Leaf Extracts on Alloxan-Induced Diabetic Rats
por: Udayakumar, Rajangam, et al.
Publicado: (2009)

Hypolipidaemic Effect of Hericium erinaceum Grown in Artemisia capillaris on Obese Rats
por: Choi, Won-Sik, et al.
Publicado: (2013)

Tumorigenicity of the hypolipidaemic peroxisome proliferator ethyl-alpha-p-chlorophenoxyisobutyrate (clofibrate) in rats.
por: Reddy, J. K., et al.
Publicado: (1979)

Hypolipidaemic Effects of High Resistant Starch Sago and Red Bean Flour- based Analog Rice on Diabetic Rats
por: Wahjuningsih, Sri Budi, et al.
Publicado: (2018)

The Role of Biofactors in Diabetic Microvascular Complications
por: Ziegler, Dan, et al.
Publicado: (2022)

Design, Synthesis and Study of Nitrogen Monoxide Donors as Potent Hypolipidaemic and Anti-Inflammatory Agents
por: Theodosis-Nobelos, Panagiotis, et al.
Publicado: (2019)

Lipid-lowering therapies and achievement of LDL-cholesterol targets
por: Rizzo, Manfredi, et al.
Publicado: (2012)

Diabetic Microvascular Complications: Novel Risk Factors, Biomarkers, and Risk Prediction Models
por: McKay, Gareth J., et al.
Publicado: (2016)

Preventing microvascular complications in type 1 diabetes mellitus
por: Viswanathan, Vijay
Publicado: (2015)

Vaccinium as Potential Therapy for Diabetes and Microvascular Complications
por: Huang, Hui, et al.
Publicado: (2023)

P465L‐PPARγ mutation confers partial resistance to the hypolipidaemic action of fibrates
por: Rodriguez‐Cuenca, Sergio, et al.
Publicado: (2018)

Mechanism‐based antioxidant therapies promise to prevent diabetic complications?
por: Nishikawa, Takeshi, et al.
Publicado: (2013)

HYPOLIPIDAEMIC EFFECTS OF MEDICAGO SATIVA SEED EXTRACTS (50% EtOH) IN RABBITS UNDER EXPERIMENTAL CONDITIONS
por: Dixit, V.P., et al.
Publicado: (1990)

Antilithiasic and Hypolipidaemic Effects of Raphanus sativus L. var. niger on Mice Fed with a Lithogenic Diet
por: Castro-Torres, Ibrahim Guillermo, et al.
Publicado: (2012)

Editorial: Cell-Based Therapies for Diabetic Microvascular Complications
por: Bhatwadekar, Ashay D.
Publicado: (2015)

Effects of Incretin-Based Therapies on Diabetic Microvascular Complications
por: Kang, Yu Mi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rblbbg4lve10c1o1l96npes6ou